FDA approves the first OTC continuous glucose monitor
The Checkup by Singlecare
MARCH 8, 2024
On March 5, 2024, the U.S. Food and Drug Administration (FDA) approved the first over-the-counter (OTC) continuous glucose monitor (CGM). Especially for people who are managing diabetes, the Stelo GCM should be used in communication with a healthcare team. Produced by DexCom, Inc., When will Stelo be available?
Let's personalize your content